Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Iterum Therapeutics Plc (ITRM)

Iterum Therapeutics Plc (ITRM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 105,096
  • Shares Outstanding, K 182,775
  • Annual Sales, $ 0 K
  • Annual Income, $ -52,010 K
  • 60-Month Beta 1.22
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.59
Trade ITRM with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.54
  • Most Recent Earnings N/A on 08/13/21
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.03
  • Number of Estimates 1
  • High Estimate -0.03
  • Low Estimate -0.03
  • Prior Year -0.34
  • Growth Rate Est. (year over year) +91.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5525 +1.92%
on 09/22/21
0.7297 -22.83%
on 08/26/21
-0.1142 (-16.86%)
since 08/23/21
3-Month
0.5525 +1.92%
on 09/22/21
2.5200 -77.65%
on 06/28/21
-1.4469 (-71.99%)
since 06/23/21
52-Week
0.4510 +24.86%
on 11/02/20
2.9950 -81.20%
on 02/11/21
-0.1067 (-15.93%)
since 09/23/20

Most Recent Stories

More News
CLASS ACTION UPDATE for ITRM, YALA and PHG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / September 23, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders...

ITRM : 0.5599 (-3.47%)
YALA : 7.82 (-1.64%)
PHG : 46.94 (+1.08%)
Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions Against ITRM, ZY & LIVE and Upcoming Lead Plaintiff Deadlines

NEW YORK, NY / ACCESSWIRE / September 23, 2021 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can...

ITRM : 0.5599 (-3.47%)
ZY : 13.62 (+1.79%)
LIVE : 37.64 (+3.35%)
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of AHCO, ITRM and SAVA

NEW YORK, NY / ACCESSWIRE / September 23, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....

AHCO : 23.42 (+0.77%)
ITRM : 0.5599 (-3.47%)
SAVA : 60.58 (+15.81%)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Iterum, View, and Spectrum and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Iterum Therapeutics plc (NASDAQ:...

ITRM : 0.5599 (-3.47%)
VIEW : 5.91 (+4.60%)
SPPI : 2.38 (+3.03%)
ITRM SHAREHOLDER CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Iterum Therapeutics plc

Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf...

ITRM : 0.5599 (-3.47%)
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ITRM, VIEW and HYRE

NEW YORK, NY / ACCESSWIRE / September 21, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....

ITRM : 0.5599 (-3.47%)
VIEW : 5.91 (+4.60%)
HYRE : 8.77 (+2.81%)
Rosen, Top Ranked Investor Counsel, Encourages Iterum Therapeutics plc Investors with Losses to Secure Counsel Before Important October 4 Deadline in Securities Class Action - ITRM

New York, New York--(Newsfile Corp. - September 21, 2021) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Iterum Therapeutics plc (NASDAQ: ITRM) between...

ITRM : 0.5599 (-3.47%)
Lawsuits Filed Against ITRM, VIEW and SESN - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / September 21, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

ITRM : 0.5599 (-3.47%)
VIEW : 5.91 (+4.60%)
SESN : 0.8990 (+12.38%)
FINAL DEADLINE APPROACHING: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Iterum Therapeutics plc and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 21, 2021 / , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Iterum Therapeutics plc ('Iterum' or 'the Company')...

ITRM : 0.5599 (-3.47%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ITRM, YALA and VIEW

NEW YORK, NY / ACCESSWIRE / September 21, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate...

ITRM : 0.5599 (-3.47%)
YALA : 7.82 (-1.64%)
VIEW : 5.91 (+4.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Iterum Therapeutics plc is a clinical-stage pharmaceutical company. It develops and markets therapies to address unmet medical needs, as well as provides anti-infectives to treat multi-drug resistant pathogens. The company's product pipeline consists of uncomplicated urinary tract infections, complicated...

See More

Key Turning Points

3rd Resistance Point 0.6382
2nd Resistance Point 0.6165
1st Resistance Point 0.5958
Last Price 0.5599
1st Support Level 0.5534
2nd Support Level 0.5317
3rd Support Level 0.5110

See More

52-Week High 2.9950
Fibonacci 61.8% 2.0232
Fibonacci 50% 1.7230
Fibonacci 38.2% 1.4228
Last Price 0.5599
52-Week Low 0.4510

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar